New poster presented at International Symposium on Minimal Residual Cancer conference

CEO Linus Bosaeus, CTO Lei Chen and Dir. BD Alexander Kele attended the ISMRC (International Symposium on Minimal Residual Cancer) Conference in Hamburg, germany, 2023, to discuss topics such as precision diagnostics, liquid biopsies and treatment monitoring and present a new poster. The poster demonstrates initial data from a pilot study looking at the utility of cfDNA mutation […]